Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia

PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

October 10, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Cervical Dystonia
Interventions
BIOLOGICAL

Botulinum toxin type A

500 units

DRUG

Placebo

500 units

Trial Locations (22)

10003

Beth Israel Medical Center, New York

90033

USC School of Medicine, Los Angeles

123367

Scientific Research Institute of Neurology, RAMS, Moscow

125047

"Clinic Cecil Plus", Moscow

194354

Municipal Multi-Speciality Hospital #2, Saint Petersburg

197022

St Petersburg Pavlov State Medical University, Saint Petersburg

Unknown

St. Joseph's Hospital and Medical Center, Phoenix

Parkinson's and Movement Disorder Institute, Fountain Valley

University of Florida, Gainesville

University of Miami, Miami

Emory University, Atlanta

Rush University Medical Center, Chicago

University of Iowa, Iowa City

University of Maryland Medical Center, Baltimore

Wayne State University Medical Center, Southfield

Albany Medical Center, Albany

Columbia University, New York

Wake Forest University, Winston-Salem

Allegeheny General, Pittsburgh

University of Texas Southwest, Dallas

Baylor College of Medicine, Houston

Swedish Neuroscience, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY